Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bladder Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 25 articles: HTML format Text format

Single Articles

January 2012
1. LI B , Wu Z, Li W, Jia G, et al
   Chlorophyllin e4 is a novel photosensitizer against human bladder cancer cells.
   Oncol Rep. 2012 Jan 26. doi: 10.3892/or.2012.1656.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. LIN HY , Huang CH, Yu TJ, Wu WJ, et al
   p53 codon 72 polymorphism as a progression index for bladder cancer.
   Oncol Rep. 2011 Dec 22. doi: 10.3892/or.2011.1610.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. ZUO Q , Wu W, Li X, Zhao L, et al
   HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin.
   Oncol Rep. 2011 Nov 15. doi: 10.3892/or.2011.1553.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. JIN Y , Murata H, Sakaguchi M, Kataoka K, et al
   Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1.
   Oncol Rep. 2011 Nov 10. doi: 10.3892/or.2011.1543.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
5. FERRO M , Giuberti G, Zappavigna S, Perdona S, et al
   Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms.
   Oncol Rep. 2011 Oct 31. doi: 10.3892/or.2011.1526.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CHEN NG , Lu CC, Lin YH, Shen WC, et al
   Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
   Oncol Rep. 2011;26:939-47.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
7. HONG SH , Choi YH
   Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells.
   Oncol Rep. 2011 Sep 7. doi: 10.3892/or.2011.1451.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
8. LI F , Ye ZQ, Guo DS, Yang WM, et al
   Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1.
   Oncol Rep. 2011 May 10. doi: 10.3892/or.2011.1304.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2011
9. YOSHITOMI T , Kawakami K, Enokida H, Chiyomaru T, et al
   Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
   Oncol Rep. 2011 Apr 8. doi: 10.3892/or.2011.1253.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TAO J , Lu Q, Wu D, Li P, et al
    microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells.
    Oncol Rep. 2011 Apr 4. doi: 10.3892/or.2011.1245.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. AWSARE NS , Martin TA, Haynes MD, Matthews PN, et al
    Claudin-11 decreases the invasiveness of bladder cancer cells.
    Oncol Rep. 2011 Apr 4. doi: 10.3892/or.2011.1244.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
12. LI F , Yang W, Guo D, Hu Z, et al
    LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway.
    Oncol Rep. 2011 Mar 22. doi: 10.3892/or.2011.1227.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. LUBET RA , Lu Y, Bode AM, You M, et al
    Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: Dose dependency and modulation of biomarkers.
    Oncol Rep. 2011 Mar 1. doi: 10.3892/or.2011.1200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. MIYAKE M , Fujimoto K, Anai S, Ohnishi S, et al
    Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
    Oncol Rep. 2011;25:653-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
15. SCHEDEL F , Pries R, Thode B, Wollmann B, et al
    mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma.
    Oncol Rep. 2011 Jan 14. doi: 10.3892/or.2011.1146.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
16. CAI T , Mazzoli S, Meacci F, Nesi G, et al
    Human papillomavirus and non-muscle invasive urothelial bladder cancer: Potential relationship from a pilot study.
    Oncol Rep. 2010 Dec 8. doi: 10.3892/or.2010.1083.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. XUE Y , Li L, Zhang D, Wu K, et al
    Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.
    Oncol Rep. 2010;24:1551-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
18. LAI PC , Chiu TH, Huang YT
    Overexpression of BDNF and TrkB in human bladder cancer specimens.
    Oncol Rep. 2010;24:1265-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
19. LI Y , Yang X, Su LJ, Flaig TW, et al
    VEGFR and EGFR inhibition increases epithelial cellular characteristics and chemotherapy sensitivity in mesenchymal bladder cancer cells.
    Oncol Rep. 2010;24:1019-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
20. GAO W , Romkes M, Zhong S, Nukui T, et al
    Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.
    Oncol Rep. 2010;24:257-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
21. NARUSE K , Yamada Y, Nakamura K, Aoki S, et al
    Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder.
    Oncol Rep. 2010;23:1577-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
22. SCHWARTZ L , Abolhassani M, Guais A, Sanders E, et al
    A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results.
    Oncol Rep. 2010;23:1407-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
23. SHAN Y , Wang X, Wang W, He C, et al
    p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells.
    Oncol Rep. 2010;23:1133-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. JAGER T , Becker M, Eisenhardt A, Tilki D, et al
    The prognostic value of cadherin switch in bladder cancer.
    Oncol Rep. 2010;23:1125-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
25. TENG XY , Liu GQ, Diao XL, Wu ZY, et al
    CAG repeats in the androgen receptor gene are shorter in patients with pulmonary, esophageal or bladder carcinoma and longer in women with uterine leiomyoma.
    Oncol Rep. 2010;23:811-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: